Pdt Partners, LLC Cytek Biosciences, Inc. Transaction History
Pdt Partners, LLC
- $1.58 Billion
- Q2 2025
A detailed history of Pdt Partners, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 91,869 shares of CTKB stock, worth $361,963. This represents 0.02% of its overall portfolio holdings.
Number of Shares
91,869
Previous 134,065
31.47%
Holding current value
$361,963
Previous $537,000
41.9%
% of portfolio
0.02%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding CTKB
# of Institutions
152Shares Held
70MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$67.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$30.6 Million0.0% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$26.2 Million0.93% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.96MShares$19.5 Million0.74% of portfolio
-
State Street Corp Boston, MA4.17MShares$16.4 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $530M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...